Skip to main content

Indaptus Therapeutics, Inc.

corporate_fare Company Profile

Indaptus Therapeutics, Inc.

INDP·NASDAQ·Life Sciences·CIK 0001857044

Indaptus Therapeutics, Inc. is a clinical biotechnology company focused on developing immunotherapy products to combat cancer and viral infections. Its primary product in development is Decoy20. This candidate is designed to be used either alone or in combination with other therapies to achieve lasting responses in various conditions. These include lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as chronic hepatitis B virus and human immunodeficiency virus infections. Decoy20 is also being developed for the treatment of advanced solid tumors. The company, which was previously known as Intec Parent, Inc., adopted the name Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is based in New York, New York.

Indaptus Therapeutics, Inc. (NASDAQ:INDP) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 37 items for INDP at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for INDP spans 10-Q, 8-K, 424B5, 424B3.

Recent high-impact activity:

  • Decoy20 Enrollment Halted as Indaptus Winds Down Clinical Work
  • Indaptus Posts $1.0M Q3 Loss, Pivots Toward Sleep-Device Research With $30.6M in Liquidity
  • Indaptus Q3 10-Q: Going-Concern Doubt Resolved, $26.6M Cash, No Active Trials
  • Indaptus Secures $24M via Private Placement at Nasdaq Minimum Price
  • Indaptus Launches $100M At-the-Market Offering with H.C. Wainwright

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$20.85M
Diluted EPS
-$21.58
Op. Cash Flow
-$14.82M
Operating Income
-$19.83M
Cash & Equivalents
$8.51M
Debt / Equity
0.00×
Shares Outstanding
2.17M sh
Source: 10-K · filed 2026-03-17 · accession 0001493152-26-010585

Short Interest & Short Volume

3.96 days to cover

FINRA reported short interest of 1,139,319 shares in INDP as of the October 30, 2026 settlement, a 33.0% increase from the prior period — about 4.0 days to cover at its recent average daily volume. On November 20, 2026, 59.5% of INDP volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,139,319 shares as of October 30, 2026
Change vs prior period▲ 33.0%
Days to cover3.96 at avg daily volume of 287,809
Daily short volume (FINRA facilities)59.5% of 117,893 shares on November 20, 2026
5-day average short volume55.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for INDP, detected from its recent SEC filings · based on capital-structure filings through 2026-09-10.

1 recent capital raiseATM program2 shelf registrations

Clerical Correction to Dilution Table · No Shares Sold Under ATM

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with I →
$2.82
52-week range · as of 2026-11-13 $0.92 – $5.96
Market cap
$433.16M
Volume
239.4K (0.8× avg)
3-mo avg 290.1K
Live data · 2026-11-21 23:48 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed INDP - Latest Insights

INDP
Nov 16, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $3.10
Real-time Price: $2.82 info
Change: -$0.280 (-9%) info
Market Cap: $433.159M info
INDP
Nov 13, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.17
Real-time Price: $2.82 info
Change: -$0.350 (-11%) info
Market Cap: $433.159M info
INDP
Nov 13, 2026, 8:30 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.15
Real-time Price: $2.82 info
Change: -$0.330 (-10%) info
Market Cap: $433.159M info
INDP
Sep 09, 2026, 9:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.11
Real-time Price: $2.82 info
Change: +$0.710 (+34%) info
Market Cap: $433.159M info
INDP
Aug 31, 2026, 9:25 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $2.82 info
Change: +$1.68 (+147%) info
Market Cap: $433.159M info
INDP
Aug 26, 2026, 4:35 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $1.16
Real-time Price: $2.82 info
Change: +$1.66 (+143%) info
Market Cap: $433.159M info
INDP
Aug 17, 2026, 5:00 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $2.82 info
Change: +$1.82 (+182%) info
Market Cap: $433.159M info
INDP
Aug 13, 2026, 7:35 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $2.82 info
Change: +$1.81 (+179%) info
Market Cap: $433.159M info
INDP
Aug 13, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.01
Real-time Price: $2.82 info
Change: +$1.81 (+179%) info
Market Cap: $433.159M info
INDP
Jul 16, 2026, 4:35 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $2.53
Real-time Price: $2.82 info
Change: +$0.290 (+11%) info
Market Cap: $433.159M info
INDP
Jun 26, 2026, 8:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $3.41
Real-time Price: $2.82 info
Change: -$0.590 (-17%) info
Market Cap: $433.159M info
INDP
Jun 26, 2026, 8:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $3.41
Real-time Price: $2.82 info
Change: -$0.590 (-17%) info
Market Cap: $433.159M info
INDP
Jun 26, 2026, 5:21 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $3.41
Real-time Price: $2.82 info
Change: -$0.590 (-17%) info
Market Cap: $433.159M info
INDP
Jun 24, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $3.55
Real-time Price: $2.82 info
Change: -$0.730 (-21%) info
Market Cap: $433.159M info
INDP
Jun 24, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.55
Real-time Price: $2.82 info
Change: -$0.730 (-21%) info
Market Cap: $433.159M info
INDP
Jun 22, 2026, 5:25 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $3.76
Real-time Price: $2.82 info
Change: -$0.9412 (-25%) info
Market Cap: $433.159M info
INDP
Jun 05, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.31
Real-time Price: $2.82 info
Change: -$0.4901 (-15%) info
Market Cap: $433.159M info
INDP
May 15, 2026, 8:15 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.75
Real-time Price: $2.82 info
Change: +$1.07 (+61%) info
Market Cap: $433.159M info
INDP
May 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.75
Real-time Price: $2.82 info
Change: +$1.07 (+61%) info
Market Cap: $433.159M info
INDP
May 15, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.75
Real-time Price: $2.82 info
Change: +$1.07 (+61%) info
Market Cap: $433.159M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets